Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A Preemptive Weapon.

Joey Berlin

    Texas Medicine
    |November 10, 2016
    PubMed
    Summary

    HIV pre-exposure prophylaxis (PrEP) can prevent HIV infection. However, awareness and access to this vital prevention method remain low in many parts of Texas.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Threat Level High: Ransomware a Bigger Threat.

    Texas medicine·2021
    Same author

    Federal Fairness? Congressional Measure Addresses Out-of-Network Payments.

    Texas medicine·2021
    Same author

    Shelter in a Storm: Liability Legislation Would Protect Physicians in Disaster.

    Texas medicine·2021
    Same author

    Medicine Trains Its Sight on Scope Expansions.

    Texas medicine·2021
    Same author

    Wrong Directive: Legal Shifts on End-of-Life Care Concern Physicians.

    Texas medicine·2021
    Same author

    Outrageous Overreach Medicine Fights Broad Documentation Requests.

    Texas medicine·2021

    Area of Science:

    • Public Health
    • Infectious Disease Prevention
    • HIV/AIDS Research

    Background:

    • The U.S. Food and Drug Administration approved HIV pre-exposure prophylaxis (PrEP) in 2012.
    • PrEP is a highly effective biomedical intervention for preventing HIV acquisition.
    • Despite its availability, significant gaps in awareness and access persist.

    Purpose of the Study:

    • To assess the awareness and accessibility of HIV pre-exposure prophylaxis (PrEP) in Texas.
    • To identify barriers to PrEP uptake among populations at high risk for HIV infection.

    Main Methods:

    • This study likely involved surveys or epidemiological data analysis within Texas.
    • Methods focused on evaluating PrEP knowledge and utilization rates.

    Main Results:

    • Awareness of PrEP is not widespread across all regions of Texas.
    • A considerable number of individuals at high risk for HIV are unaware of PrEP or how to obtain it.

    Conclusions:

    • There is a critical need to improve PrEP awareness and access in Texas.
    • Targeted outreach and education are essential to ensure equitable access to HIV prevention.